Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Researchers present first-in-human data for AT-04A

Sep. 12, 2018

AstraZeneca initiates first-in-human study of AZD-8233

Sep. 10, 2018

Soleno amends phase III trial protocol for diazoxide choline in Prader-Willi syndrome

Sep. 7, 2018

Adocia reports phase I data on BioChaperone Pramlintide Insulin in type 1 diabetes

Sep. 6, 2018

Phase I/II results with pegzilarginase in arginase deficiency support upcoming pivotal trial

Sep. 6, 2018

Proof-of-concept data presented from PHYOX phase I study of DCR-PHXC in primary hyperoxaluria

Sep. 6, 2018

FDA grants IND clearance for phase II/III study of LYS-SAF-302 for MPS IIIA

Sep. 5, 2018

OPKO Health announces initiation of phase II study of Rayaldee in dialysis patients

Sep. 5, 2018

Phase I/IIa study of SYNB-1618 in healthy volunteers establishes dose for patients with PKU

Sep. 4, 2018

HDAC inhibition can help in DNA repair syndrome

Sep. 3, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...